Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,217,092
  • Shares Outstanding, K 32,379
  • Annual Sales, $ 1,956 M
  • Annual Income, $ 126,830 K
  • 60-Month Beta 0.89
  • Price/Sales 3.18
  • Price/Cash Flow 30.86
  • Price/Book 9.13
  • Price/Earnings ttm 44.09
  • Earnings Per Share ttm 4.35
  • Most Recent Earnings 1.05 on 05/06/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.80
  • Number of Estimates 8
  • High Estimate 1.41
  • Low Estimate 0.54
  • Prior Year 1.21
  • Growth Rate Est. (year over year) -33.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
166.00 +15.67%
on 05/07/20
196.17 -2.12%
on 04/28/20
-0.49 (-0.25%)
since 04/22/20
3-Month
132.95 +44.42%
on 03/17/20
218.44 -12.10%
on 04/16/20
-2.02 (-1.04%)
since 02/21/20
52-Week
107.17 +79.16%
on 05/24/19
218.44 -12.10%
on 04/16/20
+81.19 (+73.26%)
since 05/22/19

Most Recent Stories

More News
% Return Seen to Date on SmarTrend Amedisys Inc Call (AMED)

SmarTrend identified a Downtrend for Amedisys Inc (NASDAQ:AMED) on March 19th, 2020 at $174.13. In approximately 2 months, Amedisys Inc has returned 9.08% as of today's recent price of $189.94.

AMED : 192.01 (+0.11%)
Amedisys to Present at RBC Capital Markets 2020 Global Healthcare Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at RBC...

AMED : 192.01 (+0.11%)
Amedisys to Present at the UBS Virtual Global Healthcare Conference 2020

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the...

AMED : 192.01 (+0.11%)
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

Sector ETF report for PTH

PTH : 115.89 (-0.14%)
AMED : 192.01 (+0.11%)
MASI : 246.68 (+1.67%)
WST : 211.44 (+0.20%)
XLV : 99.62 (+0.21%)
VHT : 191.02 (+0.32%)
Amedisys (AMED) Q1 Earnings Beat, Operating Margin Falls

Amedisys (AMED) notes that COVID-19 started impacting its volumes and costs beginning the second half of March.

BIIB : 304.53 (+0.02%)
AMED : 192.01 (+0.11%)
LLY : 151.16 (-0.74%)
APHA : 4.04 (+2.28%)
Amedisys (AMED) Beats Q1 Earnings Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 8.25% and -4.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

AMED : 192.01 (+0.11%)
Amedisys: 1Q Earnings Snapshot

BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported first-quarter net income of $31.8 million.

AMED : 192.01 (+0.11%)
Amedisys Reports First Quarter 2020 Financial Results

Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2020.

AMED : 192.01 (+0.11%)
Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet

Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet

AMED : 192.01 (+0.11%)
VRTX : 284.96 (+0.12%)
FN : 62.67 (+0.19%)
BABA : 199.70 (-5.87%)
Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio

Interest Coverage Ratio suggests how many times the interest could be paid from earnings and gauges the margin of safety a firm has for paying interest.

AMED : 192.01 (+0.11%)
VRTX : 284.96 (+0.12%)
FN : 62.67 (+0.19%)
BABA : 199.70 (-5.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AMED with:

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

2nd Resistance Point 195.20
1st Resistance Point 193.60
Last Price 192.01
1st Support Level 190.30
2nd Support Level 188.60

See More

52-Week High 218.44
Last Price 192.01
Fibonacci 61.8% 175.93
Fibonacci 50% 162.80
Fibonacci 38.2% 149.68
52-Week Low 107.17

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar